Generics

News

Sun Pharma reaches deal to buy out Taro in $347m deal

India’s Sun Pharma has signed an agreement to take full control of Israeli generic drugmaker Taro Pharmaceutical Industries, taking it into private hands.

News

FDA starts review of Lantheus’ generic Lutathera

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tu

Market Access

Promoting value-added medicines and renovating old medicines...

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.

News

Biogen bonus as generic Tecfidera approvals are pulled in EU

The European Commission has pulled marketing authorisations for generic versions of Biogen’s oral multiple sclerosis therapy Tecfidera, after concluding that the brand qua

News

Generics group says VPAG may lead to shortages

Among those celebrating today’s agreement on a voluntary rebate scheme for branded medicines in the UK, there are dissenting voices, including a group representing manufac

News

FTC challenges dozens of ‘improper’ US drug patents

The financial regulator in the US has sent letters to 10 companies that it claims have improperly listed patents in the FDA’s ‘Orange Book’ in order to block generic rival

Sun Pharma reaches deal to buy out Taro in $347m deal

FDA starts review of Lantheus’ generic Lutathera

Promoting value-added medicines and renovating old medicines...

Biogen bonus as generic Tecfidera approvals are pulled in EU

Generics group says VPAG may lead to shortages

FTC challenges dozens of ‘improper’ US drug patents

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Generics

Editor's Picks